\-\ Texto\\:\\ \ \(0\)\
\-\ admission\\:\ \(6\)\
\-\ physical\\ exam\\ \\-\ \(1\)\
\-\ vs\\ \\-\\ t\\ 101\\,\\ bp\\ 100\\/60\\,\\ hr\\ 96\\,\\ rr\\ 21\ \(0\)\
\-\ skin\\ \\-\\ no\\ rashes\\.\\ \ \(0\)\
\-\ heent\\ \\-\\ within\\ normal\\ limits\\.\ \(0\)\
\-\ pulm\\ \\-\\ clear\\.\\ mild\\ tachypnea\\.\ \(0\)\
\-\ heart\\ \\-\\ rrr\\,\\ no\\ murmurs\\.\\ \ \(0\)\
\-\ abd\\ \\-\\ soft\\,\\ nt\\.\\ \\ \ \(0\)\
\-\ labs\\ \\-\\ \ \(0\)\
\-\ wbc\\ 1\\.0\\ k\\/ul\\ \\(4\\.0\\ \\-\\ 11\\.0\\ k\\/ul\\)\ \(0\)\
\-\ hgb\\ 8\\.2\ \(0\)\
\-\ hct\\ 24\ \(0\)\
\-\ plt\\ 30\ \(0\)\
\-\ bun\\/cr\\ 28\\/12\\.1\ \(0\)\
\-\ gluc\\ 111\ \(0\)\
\-\ iv\\ amphotericin\\ b\\ or\\ an\\ oral\\ azole\\ \\(fluconazole\\ v\\ itraconazole\\)\\.\ \(0\)\
\-\ ct\\ pe\\/dvt\\ protocol\\ 8\\/27\\/2004\\ \\(admission\\)\\:\\ \ \(0\)\
\-\ neg\\ for\\ pe\\.\\ no\\ infiltrates\\,\\ pleural\\ effusions\\,\\ pneumothoraces\\.\ \(0\)\
\-\ ct\\ a\\/p\\ 09\\/01\\/2004\\:\\ \ \(0\)\
\-\ bibasilar\\ lung\\ nodules\\ \\-\\ new\\.\ \(0\)\
\-\ ct\\ chest\\ 09\\/02\\/2004\\:\\ \ \(0\)\
\-\ diffuse\\,\\ bilateral\\,\\ panlobar\\ \\(bases\\ \\>\\ apices\\)\\ pulmonary\\ nodules\\.\ \(0\)\
\-\ invasive\\ bronchopulmonary\\ aspergillosis\ \(0\)\
\-\ immunocompromised\\ with\\ nodular\\ lung\\ pattern\\:\ \(0\)\
\-\ \\(25\\%\\ noninfectious\\/75\\%\\ infectious\\)\ \(1\)\
\-\ 1\\)\\ fungal\\ infection\ \(0\)\
\-\ aspergillus\ \(2\)\
\-\ coccidoides\ \(0\)\
\-\ cryptococcus\ \(1\)\
\-\ mucor\ \(3\)\
\-\ 2\\)\\ nocardia\ \(0\)\
\-\ 3\\)\\ legionella\ \(0\)\
\-\ 4\\)\\ neoplasm\ \(0\)\
\-\ 49\\ y\\.o\\.\\ man\\ with\\ non\\ hodgkins\\ lymohoma\\ presents\\ to\\ the\\ hospital\\ 10\\ days\\ after\\ his\\ last\\ round\\ of\\ chemotherapy\\ with\\ neutropenic\\ fever\\ and\\ shortness\\ of\\ breath\\.\ \(0\)\
\-\ differential\\ is\\ for\\ a\\ neutropenic\\ patient\\ with\\ a\\ particular\\ imaging\\ pattern\\ ie\\,\\ in\\ this\\ case\\,\\ \\&\\#39\\;nodular\\&\\#39\\;\\ \\(vice\\ \\&\\#39\\;diffuse\\/non\\ nodular\\&\\#39\\;\\ or\\ \\&\\#39\\;segmental\\/consolidative\\&\\#39\\;\\)\\.\\ it\\ is\\ acute\\ onset\\ which\\ is\\ highly\\ suggestive\\ of\\ infection\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ \\-\\:\\ 0\\.10017265008561363\ \(0\)\
\-\ 39\\:\\ 0\\.09307807822284157\ \(0\)\
\-\ \\#\\:\\ 0\\.07855515513142707\ \(0\)\
\-\ \\&\\:\\ 0\\.0703450287220648\ \(0\)\
\-\ neutropenic\\:\\ 0\\.05804081299098912\ \(0\)\
\-\ k\\/ul\\:\\ 0\\.05170542067679905\ \(0\)\
\-\ \\;\\:\\ 0\\.047470809104357664\ \(0\)\
\-\ nodular\\:\\ 0\\.042004802427092716\ \(0\)\
\-\ 28\\/12\\.1\\:\\ 0\\.034435618843619134\ \(0\)\
\-\ 8\\/27\\/2004\\:\\ 0\\.034435618843619134\ \(0\)\
\-\ 09\\/01\\/2004\\:\\ 0\\.034435618843619134\ \(0\)\
\-\ 09\\/02\\/2004\\:\\ 0\\.034435618843619134\ \(0\)\
\-\ panlobar\\:\\ 0\\.034435618843619134\ \(0\)\
\-\ noninfectious\\/75\\:\\ 0\\.034435618843619134\ \(0\)\
\-\ coccidoides\\:\\ 0\\.034435618843619134\ \(0\)\
\-\ lymohoma\\:\\ 0\\.034435618843619134\ \(0\)\
\-\ diffuse\\/non\\:\\ 0\\.034435618843619134\ \(0\)\
\-\ segmental\\/consolidative\\:\\ 0\\.034435618843619134\ \(0\)\
\-\ 100\\/60\\:\\ 0\\.03172801266955685\ \(0\)\
\-\ azole\\:\\ 0\\.03172801266955685\ \(0\)\
\-\ mucor\\:\\ 0\\.03172801266955685\ \(0\)\
\-\ admission\\:\\ 0\\.02941923763060126\ \(0\)\
\-\ 8\\.2\\:\\ 0\\.02902040649549456\ \(0\)\
\-\ vice\\:\\ 0\\.02902040649549456\ \(0\)\
\-\ fluconazole\\:\\ 0\\.02814875199817343\ \(0\)\
\-\ nocardia\\:\\ 0\\.02814875199817343\ \(0\)\
\-\ \\)\\:\\ 0\\.02787256609817598\ \(0\)\
\-\ nodules\\:\\ 0\\.027675928635958996\ \(0\)\
\-\ bun\\/cr\\:\\ 0\\.027436558416947043\ \(0\)\
\-\ gluc\\:\\ 0\\.027436558416947043\ \(0\)\
\-\ itraconazole\\:\\ 0\\.026312800321432274\ \(0\)\
\-\ a\\/p\\:\\ 0\\.026312800321432274\ \(0\)\
\-\ cryptococcus\\:\\ 0\\.026312800321432274\ \(0\)\
\-\ legionella\\:\\ 0\\.026312800321432274\ \(0\)\
\-\ 11\\.0\\:\\ 0\\.025852710338399525\ \(0\)\
\-\ pneumothoraces\\:\\ 0\\.025852710338399525\ \(0\)\
\-\ pattern\\:\\ 0\\.02551908077399436\ \(0\)\
\-\ nt\\:\\ 0\\.025441145824111142\ \(0\)\
\-\ hodgkins\\:\\ 0\\.025441145824111142\ \(0\)\
\-\ 101\\:\\ 0\\.024728952242884756\ \(0\)\
\-\ 4\\.0\\:\\ 0\\.024728952242884756\ \(0\)\
\-\ 111\\:\\ 0\\.024728952242884756\ \(0\)\
\-\ amphotericin\\:\\ 0\\.024728952242884756\ \(0\)\
\-\ apices\\:\\ 0\\.024728952242884756\ \(0\)\
\-\ aspergillus\\:\\ 0\\.024728952242884756\ \(0\)\
\-\ pe\\/dvt\\:\\ 0\\.023857297745563624\ \(0\)\
\-\ immunocompromised\\:\\ 0\\.023857297745563624\ \(0\)\
\-\ bronchopulmonary\\:\\ 0\\.02336837921839954\ \(0\)\
\-\ aspergillosis\\:\\ 0\\.02336837921839954\ \(0\)\
\-\ 96\\:\\ 0\\.02314510416433724\ \(0\)\
\-\ rashes\\:\\ 0\\.022933904081250227\ \(0\)\
\-\ pulm\\:\\ 0\\.022187594562645893\ \(0\)\
\-\ \\:\\:\\ 0\\.022075679999817677\ \(0\)\
\-\ ie\\:\\ 0\\.021708679241972718\ \(0\)\
\-\ bibasilar\\:\\ 0\\.021561256085789723\ \(0\)\
\-\ plt\\:\\ 0\\.021282119507734468\ \(0\)\
\-\ 1\\.0\\:\\ 0\\.020777386181640694\ \(0\)\
\-\ infiltrates\\:\\ 0\\.020777386181640694\ \(0\)\
\-\ neg\\:\\ 0\\.020437497990274955\ \(0\)\
\-\ tachypnea\\:\\ 0\\.019835346897199724\ \(0\)\
\-\ infection\\:\\ 0\\.019406379484943805\ \(0\)\
\-\ lung\\:\\ 0\\.019337180626865205\ \(0\)\
\-\ bases\\:\\ 0\\.019076924965789735\ \(0\)\
\-\ hgb\\:\\ 0\\.018574513333672184\ \(0\)\
\-\ 49\\:\\ 0\\.018507738203362416\ \(0\)\
\-\ v\\:\\ 0\\.018314000152036745\ \(0\)\
\-\ hct\\:\\ 0\\.0181294185705893\ \(0\)\
\-\ murmurs\\:\\ 0\\.017953166870274966\ \(0\)\
\-\ protocol\\:\\ 0\\.017953166870274966\ \(0\)\
\-\ particular\\:\\ 0\\.01789614031003609\ \(0\)\
\-\ abd\\:\\ 0\\.017676011651633232\ \(0\)\
\-\ rr\\:\\ 0\\.017035824717628868\ \(0\)\
\-\ rrr\\:\\ 0\\.017035824717628868\ \(0\)\
\-\ effusions\\:\\ 0\\.017035824717628868\ \(0\)\
\-\ \\(\\:\\ 0\\.016930352958840482\ \(0\)\
\-\ invasive\\:\\ 0\\.01677238221452132\ \(0\)\
\-\ hr\\:\\ 0\\.01625608622581631\ \(0\)\
\-\ fungal\\:\\ 0\\.01618238120900231\ \(0\)\
\-\ heent\\:\\ 0\\.01614604373766515\ \(0\)\
\-\ highly\\:\\ 0\\.016074367414742507\ \(0\)\
\-\ b\\:\\ 0\\.015734479223376768\ \(0\)\
\-\ \\%\\:\\ 0\\.015572820573015685\ \(0\)\
\-\ t\\:\\ 0\\.015451976639081351\ \(0\)\
\-\ 21\\:\\ 0\\.015104525521829414\ \(0\)\
\-\ pe\\:\\ 0\\.014995252662288764\ \(0\)\
\-\ bp\\:\\ 0\\.01449051933619499\ \(0\)\
\-\ round\\:\\ 0\\.014420134549075153\ \(0\)\
\-\ infectious\\:\\ 0\\.014350995576030617\ \(0\)\
\-\ last\\:\\ 0\\.014260673632980407\ \(0\)\
\-\ suggestive\\:\\ 0\\.014260673632980407\ \(0\)\
\-\ oral\\:\\ 0\\.014064776040459033\ \(0\)\
\-\ shortness\\:\\ 0\\.014043603901906928\ \(0\)\
\-\ ct\\:\\ 0\\.014007464688188004\ \(0\)\
\-\ non\\:\\ 0\\.013798104278236367\ \(0\)\
\-\ limits\\:\\ 0\\.013758646872039086\ \(0\)\
\-\ 25\\:\\ 0\\.01349307132131669\ \(0\)\
\-\ vs\\:\\ 0\\.013142499884378116\ \(0\)\
\-\ 24\\:\\ 0\\.012978347580570116\ \(0\)\
\-\ pleural\\:\\ 0\\.012962305463567563\ \(0\)\
\-\ 30\\:\\ 0\\.012836286470527637\ \(0\)\
\-\ skin\\:\\ 0\\.012820816153277258\ \(0\)\
\-\ hospital\\:\\ 0\\.012566783066281732\ \(0\)\
\-\ breath\\:\\ 0\\.012480927961911517\ \(0\)\
\-\ clear\\:\\ 0\\.012341900832604084\ \(0\)\
\-\ iv\\:\\ 0\\.012181347411957397\ \(0\)\
\-\ wbc\\:\\ 0\\.012168261135061765\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.011964631973206505\ \(0\)\
\-\ \\,\\:\\ 0\\.011632073127695942\ \(0\)\
\-\ new\\:\\ 0\\.011631984284377181\ \(0\)\
\-\ labs\\:\\ 0\\.011609273464590383\ \(0\)\
\-\ heart\\:\\ 0\\.011597967378549899\ \(0\)\
\-\ neoplasm\\:\\ 0\\.01136779912465597\ \(0\)\
\-\ fever\\:\\ 0\\.011293994634968618\ \(0\)\
\-\ 10\\:\\ 0\\.011252438391980119\ \(0\)\
\-\ \\>\\:\\ 0\\.01109049810417408\ \(0\)\
\-\ differential\\:\\ 0\\.010597499333409881\ \(0\)\
\-\ onset\\:\\ 0\\.010536801663770117\ \(0\)\
\-\ days\\:\\ 0\\.010230758969421787\ \(0\)\
\-\ diffuse\\:\\ 0\\.010105497735841074\ \(0\)\
\-\ no\\:\\ 0\\.010083329891060179\ \(0\)\
\-\ pulmonary\\:\\ 0\\.009752149649297123\ \(0\)\
\-\ y\\.o\\:\\ 0\\.009634294658541797\ \(0\)\
\-\ his\\:\\ 0\\.009620660264245828\ \(0\)\
\-\ 4\\:\\ 0\\.009300671504605645\ \(0\)\
\-\ mild\\:\\ 0\\.008790052554418504\ \(0\)\
\-\ acute\\:\\ 0\\.008241716129322247\ \(0\)\
\-\ physical\\:\\ 0\\.008189473709301712\ \(0\)\
\-\ soft\\:\\ 0\\.008128620171849805\ \(0\)\
\-\ bilateral\\:\\ 0\\.008100850505134547\ \(0\)\
\-\ chest\\:\\ 0\\.007987222656474682\ \(0\)\
\-\ 1\\:\\ 0\\.007942681124842605\ \(0\)\
\-\ man\\:\\ 0\\.00789426501207031\ \(0\)\
\-\ or\\:\\ 0\\.007824396476278965\ \(0\)\
\-\ imaging\\:\\ 0\\.007820600876779698\ \(0\)\
\-\ 3\\:\\ 0\\.00781631065119742\ \(0\)\
\-\ it\\:\\ 0\\.007503314002082096\ \(0\)\
\-\ exam\\:\\ 0\\.007332945077927883\ \(0\)\
\-\ case\\:\\ 0\\.007302751690887776\ \(0\)\
\-\ 2\\:\\ 0\\.007187908189494321\ \(0\)\
\-\ after\\:\\ 0\\.006906254697692197\ \(0\)\
\-\ presents\\:\\ 0\\.0068189230293278355\ \(0\)\
\-\ is\\:\\ 0\\.006589345059196004\ \(0\)\
\-\ within\\:\\ 0\\.006367700814008131\ \(0\)\
\-\ which\\:\\ 0\\.006231033543916206\ \(0\)\
\-\ for\\:\\ 0\\.005696157411271212\ \(0\)\
\-\ normal\\:\\ 0\\.0052328611507777385\ \(0\)\
\-\ an\\:\\ 0\\.004615878376112226\ \(0\)\
\-\ this\\:\\ 0\\.003754442239508332\ \(0\)\
\-\ patient\\:\\ 0\\.0033460622301421405\ \(0\)\
\-\ a\\:\\ 0\\.0030984359517078224\ \(0\)\
\-\ \\.\\:\\ 0\\.0020800509432038834\ \(0\)\
\-\ with\\:\\ 0\\.0018281902514045271\ \(0\)\
\-\ to\\:\\ 0\\.001668234798605415\ \(0\)\
\-\ in\\:\\ 0\\.0016460829302353708\ \(0\)\
\-\ of\\:\\ 0\\.0013652789156014269\ \(0\)\
\-\ and\\:\\ 0\\.0007031601786414783\ \(0\)\
\-\ the\\:\\ 0\\.0005400362683735383\ \(0\)\
